Bench to bedside: A role for erythropoietin in sepsis
Open Access
- 1 January 2010
- journal article
- review article
- Published by Springer Nature in Critical Care
- Vol. 14 (4) , 227
Abstract
Sepsis is the systemic inflammatory response to infection and can result in multiple organ dysfunction syndrome with associated high mortality, morbidity and health costs. Erythropoietin is a well-established treatment for the anaemia of renal failure due to its anti-apoptotic effects on red blood cells and their precursors. The extra-haemopoietic actions of erythropoietin include vasopressor, anti-apoptotic, cytoprotective and immunomodulating actions, all of which could prove beneficial in sepsis. Attenuation of organ dysfunction has been shown in several animal models and its vasopressor effects have been well characterised in laboratory and clinical settings. Clinical trials of erythropoietin in single organ disorders have suggested promising cytoprotective effects, and while no randomised trials have been performed in patients with sepsis, good quality data exist from studies on anaemia in critically ill patients, giving useful information of its pharmacokinetics and potential for harm. An observational cohort study examining the microvascular effects of erythropoietin is underway and the evidence would support further phase II and III clinical trials examining this molecule as an adjunctive treatment in sepsis.Keywords
This publication has 104 references indexed in Scilit:
- Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietinProceedings of the National Academy of Sciences, 2008
- Recombinant human erythropoietin increases survival and reduces neuronal apoptosis in a murine model of cerebral malariaMalaria Journal, 2008
- Erythropoietin-receptor agonists in critically ill patients: a meta-analysis of randomized controlled trialsCanadian Medical Association Journal, 2007
- Activities of erythropoietin on tumors: An immunological perspectiveEuropean Journal of Immunology, 2007
- Erythropoietin improves skeletal muscle microcirculation and tissue bioenergetics in a mouse sepsis modelCritical Care, 2007
- Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activitiesProceedings of the National Academy of Sciences, 2006
- Emerging biological roles for erythropoietin in the nervous systemNature Reviews Neuroscience, 2005
- New Avenues of Exploration for ErythropoietinJAMA, 2005
- Erythropoietin as an antiapoptotic, tissue-protective cytokineCell Death & Differentiation, 2004
- The Pathophysiology and Treatment of SepsisNew England Journal of Medicine, 2003